ACORN BIOVENTURES 2, L.P.

Insider Reports History

Location
New York, NY
Signature
ACORN BIOVENTURES 2, L.P., By: Acorn Capital Advisors GP 2, LLC, its general partner, By: /s/ Anders Hove, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ACORN BIOVENTURES 2, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. 10%+ Owner Common Stock 1,129,730 $2,869,514 $2.54 15 May 2025 Direct

Insider Reports Filed by ACORN BIOVENTURES 2, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 15 May 2025 0 $0 3 10%+ Owner 27 May 2025, 19:44